Inactive

The Centers for Disease Control and Prevention intends to award, on a sole source basis, a cost reimbursable contract to the University of Arizona, 888 N Euclid Ave RM 510, Tucson, AZ 85719, for an ev... The Centers for Disease Control and Prevention intends to award, on a sole source basis, a cost reimbursable contract to the University of Arizona, 888 N Euclid Ave RM 510, Tucson, AZ 85719, for an evaluation of the field performance of COVID-19 vaccines, including immunogenicity and effectiveness among essential and frontline workers with and without prior SARs-CoV-2 infections. The University of Arizona initiated the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance Study (AZ HEROES) prospective cohort in August 2020 and since then has enrolled and maintained a cohort of over 3,000 participants. No other existing cohort includes the number and composition of participants (many of whom are high-risk for COVID-19), with rigorous follow-up and extensive laboratory and clinical data collection required for these evaluations. Continuing the existing cohort will allow CDC to efficiently and expediently assess the effect of booster does and VE against new and future variants. Additionally, CDC requires that vaccine evaluations be implemented consistent with study design features and methodologies of other CDC funded COVID-19 cohorts. AZ HEROES has an ongoing collaboration and coordination with the Research on the Epidemiology of SARs-CoV-2 in Essential Response Personnel (RECOVER) cohorts in 6 US cities. This collaboration and their use of common surveillance and laboratory methods ensures that CDC is able to compare and combine results across cohorts in a valid, reliable, and timely manner, increasing the sample size to allow for more precise findings improve generalizability of finds by capturing more diverse populations. The anticipated period of performance is from 15 June 2022 through 14 June 2023. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive offers; however, all offers/responses received within 15 days of the issuance of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. All offers/responses should be emailed to Mark Draluck at syq1@cdc.gov by 11:00 A.M. Eastern Time, 6 April 2022.